Act Beta-defensin 2 (18-40)[C12I,G14p,P15G,C-del]

General Information


DRACP ID  DRACP03570

Peptide Name   Act Beta-defensin 2 (18-40)[C12I,G14p,P15G,C-del]

Sequence  RCpGRTRQIGTIFpGRIKCRSW

Sequence Length  22

UniProt ID  P46160 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Acetylation

C-terminal Modification  Free

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C102H168N38O23S2

Absent amino acids  ADEHLMNPVY

Common amino acids  R

Mass  273356

Pl  12.33

Basic residues  6

Acidic residues  0

Hydrophobic residues  5

Net charge  6

Boman Index  -6878

Hydrophobicity  -58.64

Aliphatic Index  53.18

Half Life 
  /

Extinction Coefficient cystines  5625

Absorbance 280nm  267.86

Polar residues  8

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 25791057

Title  N-terminal fatty acylation of peptides spanning the cationic C-terminal segment of bovine ?-defensin-2 results in salt-resistant antibacterial activity

Doi Not available

Year  2015

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  7713

DRACP is developed by Dr.Zheng's team.